|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Department of Internal Medicine (Dr. Terashima and Ms. Matsumaru), Tokyo Dental College Ichikawa General Hospital, Ichikawa, Chiba; Department of Internal Medicine (Drs. Amakawa and Yamaguchi), School of Medicine, Keio University, Shinjuku, Tokyo; and Pulmonary Research Laboratory (Drs. Eeden and Hogg), St. Pauls Hospital, Vancouver, British Columbia, Canada.
Correspondence to: Takeshi Terashima, MD, PhD, Department of Internal Medicine, Tokyo Dental College Ichikawa General Hospital, 511-13, Sugano, Ichikawa, Chiba, 272-0824, Japan; e-mail: terasima{at}tdc.ac.jp
| Abstract |
|---|
|
|
|---|
Design and methods: WBC counts and plasma cytokines were measured before and 4 h after fiberoptic bronchoscopy (FOB) without further interventions (n = 6), or combined with BAL in normal volunteer subjects (n = 6), and in patients with bacterial pneumonia (n = 4). The bronchus of the right middle lobe was wedged, and three 50-mL aliquots of sterile saline solution was instilled. There was no endotoxin contamination in the saline solution or the fluid obtained through the working channel of bronchoscope.
Results: In volunteers, peripheral WBC
counts and the number of nonsegmented and segmented neutrophils
increased after the BAL procedure (p < 0.05) associated with the
increase in plasma concentration (mean ± SEM) of interleukin
(IL)-6 (0.99 ± 0.32 pg/mL before BAL and 20.38 ± 13.42 pg/mL
after BAL; p < 0.05) and granulocyte colony-stimulating factor
(G-CSF; 14.1 ± 1.7 pg/mL before BAL and 38.5 ± 9.7 pg/mL after
BAL; p < 0.05). The increase in WBC counts and neutrophil counts was
positively correlated to the increase in IL-6 (p < 0.05) and the
increase in G-CSF (p < 0.05). In patients with pneumonia, IL-6 and
G-CSF levels were higher after BAL than in normal volunteer subjects
(p < 0.05). There was no increase in plasma concentration of
IL-1ß, tumor necrosis factor-
, or IL-8 after BAL in normal
volunteer subjects or in patients with pneumonia. FOB without BAL did
not increase the WBC count, neutrophil count, or plasma cytokine
levels.
Conclusion: The BAL procedure increases the number of WBCs, and segmented and nonsegmented neutrophils in the peripheral circulation as well as circulating IL-6 and G-CSF levels.
Key Words: BAL granulocyte colony-stimulating factor interleukin-6 neutrophilia
| Introduction |
|---|
|
|
|---|
, interleukin
(IL)-1ß, and IL-6, induce fever after BAL in the patients with
interstitial lung diseases.1
In these patients, the serum
concentration of TNF-
was high before BAL, and the patients with
elevated IL-1ß concentrations before BAL were more likely to develop
fever than were patients with normal cytokine values. This study
suggests that the BAL procedure induces a systemic inflammatory
response characterized by an increase in circulating cytokine levels.
A systemic inflammatory reaction has been described in the systemic
inflammatory response syndrome (SIRS). The SIRS can be elicited by a
wide variety of insults, such as trauma, hemorrhagic shock, and
septicemia.3
A neutrophilia associated with an increase in
the percentage of immature (nonsegmented) neutrophils can be seen
during SIRS.3
Macrophages and their products, such as
TNF-
, IL-1, and IL-8, and neutrophils have been implicated in the
pathogenesis of SIRS.4
5
Several studies6
7
8
have suggested that immature neutrophils are less deformable and more
likely to sequester in the lung. In these studies,6
7
8
newly released neutrophils have been implicated in mediating
endothelial injury in pulmonary microvasculature. These neutrophils may
be released from bone marrow by inflammatory cytokines, such as
TNF-
,9
IL-1,9
IL-6, 10
IL-8,11
12
13
and granulocyte colony-stimulating factor
(G-CSF).14
In humans, studies15
have shown
that BAL causes neutrophil recruitment in the lower bronchial and
alveolar spaces, and the signals for these recruitment could be
inflammatory cytokines released from alveolar cells such as alveolar
macrophages.
We hypothesized that BAL causes a systemic inflammatory response that is characterized by circulating cytokines capable of stimulating the bone marrow to release neutrophils. We postulated that mediators released from the lung contribute to this systemic response. To test these hypotheses, blood cell counts including differentiated WBC counts as well as plasma cytokine levels were measured before and 4 h after fiberoptic bronchoscopy (FOB) with or without BAL in normal healthy volunteer subjects and also in patients with bacterial pneumonia. We expected a systemic inflammatory response 4 h after FOB because increased concentrations of inflammatory cytokines have been reported 4 h after BAL, but not at later times.16
| Materials and Methods |
|---|
|
|
|---|
Each subject was premedicated with an IM injection of atropine, 0.5 mg, and hydroxyzine, 25 mg. Local anesthesia of the pharynx and laryngeal area was performed with the inhalation and spray of 4% lidocaine aerosol. Topical anesthesia of the trachea and the bronchial system was obtained by the direct application of 4% lidocaine administered in 1-mL boluses via the working channel of the bronchoscope. The bronchus of the right middle lobe was wedged, and three 50-mL aliquots of a 0.9% sterile saline solution at room temperature was instilled with a syringe through the working channel of the bronchoscope. BAL fluid was recovered by manual aspiration using the attached syringe. The total volume of saline solution instilled into the lung was 150 mL, and 70 to 110 mL of BAL fluid was recovered. The number of cells was counted (model SE-9000; Sysmex; Kobe, Japan). Cytospin with Diff Quick stain (Sigma Chemical; St. Louis, MO) was performed to obtain differential cell counts. Cell differential counts yielded 95.6 ± 0.3% macrophages, 3.1 ± 0.2% lymphocytes, and 1.1 ± 0.1% neutrophils (mean ± SEM). The viability of these cells was assessed with 0.01% trypan blue; > 95% of the cells were viable. In the FOB group, each subject underwent FOB with the same anesthesia and the bronchus of the right middle lobe was wedged, but without further interventions.
BAL Procedure in Patients With Infectious Pneumonia
To investigate the effects of the BAL procedure in patients with
infection, BAL was carried out in four patients with suspected
community-acquired bacterial pneumonia. The patients were from 32 to 64
years old, three were women, and no patients had comorbid conditions
such as bronchial asthma, COPD, heart failure, renal failure, or
impaired immunity. The BAL in these patients was done to obtain
bacterial culture (pneumonia group, n = 4). The chest radiograph of
three patients showed consolidation in the right lower lobe, and in the
left lower lobe in the other patient. BAL was done in the lobe of
consolidation. The BAL procedure was done as described before. The
bronchus of the lobe with consolidation imaged with either chest
radiograph or chest CT scan was wedged, and 50 mL of 0.9% sterile
saline solution at room temperature was instilled with a syringe
through the working channel of the bronchoscope. The total volume of
saline solution instilled into the lung was 150 mL, and 50 to 100 mL of
BAL fluid was recovered. Cell differential counts yielded
27.0 ± 3.3% macrophages, 11.3 ± 4.6% lymphocytes, and
61.8 ± 6.7% neutrophils. The recovered fluid was also used for
microbiological investigation.
Endotoxin Measurement of Instilled Saline Solution
In order to determine whether fluids instilled through the
bronchoscope could be contaminated with endotoxin, both instilled
saline solution and the saline aliquots obtained through the working
channel of bronchoscope were tested using the limulus amebocytes lysate
method (E-Toxate; Sigma Chemical). This is a semiquantitative assay
with a sensitivity of 0.1 endotoxin units per milliliter.
Leukocytes Counts
Blood samples were obtained from the cubital vein before and
4 h after the bronchoscopy. Blood cell counts were determined on a
model SE-9000 (Sysmex), and differential WBC counts were done on
Wrights stained blood smears.
Cytokine Assay
Plasma concentrations of the cytokines were determined using
commercially available enzyme-linked immunosorbent assay (ELISA) kits.
TNF-
, IL-1, and IL-6 were determined by Quantikine high-sensitivity
ELISA kits (R&D Systems; Minneapolis, MN). The lower ranges of the test
were 0.5 pg/mL for TNF-
, 0.125 pg/mL for IL-1ß, and 0.156 pg/mL
for IL-6, respectively. IL-8 and granulocyte-macrophage
colony-stimulating factor (GM-CSF) were determined by Biotrak ELISA
kits (Amersham; Buckinghamshire, UK). The lower ranges of the test were
10.0 pg/mL for IL-8 and 2.0 pg/mL for GM-CSF. G-CSF was determined
using chemiluminescence enzyme immunoassay method18
(G-CSF
CLEIA kit; Chugai Pharmaceutical; Tokyo, Japan), and the lower
range of the test was 1.0 pg/mL.
Statistical Analysis
Data are expressed as mean ± SEM, and differences between
groups were evaluated by analysis of variance. If differences between
groups were significant (p < 0.05), Fishers protected least
difference test was used as a post hoc test. The values
before and 4 h after the BAL were compared using a paired
t test. The level of p < 0.05 was accepted as
statistically significant.
| Results |
|---|
|
|
|---|
Hemodynamics and Fever
There were no differences in BP or heart rate before and after
bronchoscopy with or without the BAL procedure, suggesting that there
were no differences in cardiac output or pulmonary blood flow. None of
the normal volunteer subjects developed fever after bronchoscopy
without interventions or with BAL. In patients with bacterial
pneumonia, three of four patients developed a fever and tachycardia
4 h after BAL. One of the subjects had fever before the procedure,
and two others developed fever after BAL.
Peripheral Blood
Table 1
showed the number of WBC counts, nonsegmented and segmented
neutrophils, eosinophils, basophils, lymphocytes, and monocytes. The
peripheral WBC counts and the number of nonsegmented and segmented
neutrophils increased after the BAL procedure in normal volunteers
(p < 0.05) and in the patients with pneumonia (p < 0.05). There
was no increase in the number of WBCs or nonsegmented and segmented
neutrophils after bronchoscopy without BAL. The number of eosinophils,
basophils, monocytes, or lymphocytes did not change after bronchoscopy
with or without BAL.
|
and IL-1ß were similar in all groups and
did not increase after bronchoscopy with or without BAL. The plasma
concentration of IL-6 before bronchoscopy was higher in the pneumonia
group than in the FOB and BAL groups (p < 0.05). The plasma
concentration of IL-6 did not change after bronchoscopy without BAL in
the normal volunteers (FOB group). The plasma concentration of IL-6
increased after BAL in normal volunteers (BAL group) and in patients
with pneumonia (pneumonia group; p < 0.05). The plasma concentration
of IL-6 after BAL was higher in the pneumonia group than in the BAL and
FOB groups (p < 0.05). The plasma concentrations of IL-8 were below
the sensitivity before or after BAL in normal volunteers (< 10.0
pg/mL) and did not increase after BAL. The plasma concentration of
G-CSF did not differ among the groups before the bronchoscopy, and did
not increase after bronchoscopy without BAL in the normal volunteer
subjects (FOB group). The BAL increased the plasma concentration of
G-CSF in the normal volunteer subjects and in the pneumonia group
(p < 0.05). The plasma concentration of G-CSF after BAL was higher
in the pneumonia group than in the BAL and FOB groups (p < 0.05).
The plasma concentrations of GM-CSF were below the sensitivity in all
groups (< 2.0 pg/mL).
|
| Discussion |
|---|
|
|
|---|
Bronchoscopy and BAL induce flu-like symptoms, headache, and fever in
up to one third of subjects; fever is more likely when topical
anesthetic is instilled through the working channel of the bronchoscope
rather than administered by nebulization.1
Nelson and his
colleagues16
have shown the endotoxin contamination of the
lungs during bronchoscopy and suggested that this endotoxin could
induce intrapulmonary accumulation of IL-8, IL-1ß, and TNF-
. We
have used endotoxin-free saline solution to do the BAL, and no subjects
developed a fever or a TNF-
response. There was no endotoxin
contamination in the samples obtained through the working channel of
the bronchoscope. This suggests that endotoxin was not responsible for
the systemic inflammation we observed.
The lack of an increase in the plasma cytokine levels after bronchoscopy without BAL suggests that the BAL procedure rather than the bronchoscopy induced the cytokine response, which is supported by studies in children.19 The mechanisms of the cytokine release by BAL are unclear. The physical process of collecting cells such as the negative pressure with suction could be important in generating the release of cytokines. Alternatively, the changes in surface potency or surface tension induced by the saline solution instillation could stimulate cells. The cell types that released the cytokines include activated monocytes and macrophages,20 and because macrophages are the predominant cell type in the lung alveoli, it is likely that they are the main source of cytokine production by the BAL procedure.
We showed that the increases of WBC and neutrophil counts were positively correlated with the increases in IL-6 and G-CSF. G-CSF increases the production and release of segmented and nonsegmented neutrophils from the bone marrow and alters neutrophil functions,21 22 and we suspect that G-CSF contributed to the neutrophilia after BAL. Endogenous G-CSF serum levels have been shown to be increased as much as 30-fold in patients with severe infection.23 In the present study, the BAL procedure induced a 2.7-fold increase in the G-CSF concentration in the normal volunteer subjects and a 10-fold increase in patients with pneumonia. The presence of large numbers of inflammatory cells and priming of these cells in the pneumonic process could be responsible for the enhanced cytokine release.
IL-6 is a pleiotropic cytokine involved in the regulation of the immune response, the acute-phase reaction, and hematopoiesis,24 enhancing IL-3 dependent proliferation of multipotential hematopoietic progenitors in vitro.25 IV administration of IL-6 induces a biphasic neutrophilia with an initial peak at 1.5 h because of demargination and a second neutrophilia between 4 h and 12 h because of release of marrow neutrophils.10 26 IL-6 also induces corticosteroid release,24 27 and we have shown that dexamethasone causes a neutrophilia primary by demargination with a minor contribution from bone marrow.28 Although the increase in the nonsegmented neutrophils signifies a definite bone marrow release response, the high levels of IL-6 induced by the BAL procedure suggest that demargination of intravascular neutrophils also contributed to the neutrophilia we observed. Whether by inducing bone marrow release or by demargination, it is likely that IL-6 significantly contributes to the neutrophilia induced by BAL.
Catecholamines, exercise, and an increase in cardiac output are known to induce an increase in the number of circulating neutrophils by shifting cells from the marginated pool into the circulation.29 30 31 This demargination is not associated with an increase in circulating nonsegmented neutrophils,32 in contrast to the neutrophilia we observed after BAL. We did not observe any hemodynamic changes during or after the BAL procedure, suggesting that these changes are unlikely to be responsible for the neutrophilia we observed.
Elevated levels of the cytokines, TNF-
, IL-1ß, and IL-6, have been
suggested to contribute to the systemic inflammatory response after BAL
in patients with interstitial lung disease.1
We have shown
that BAL in normal volunteer subjects also induced the release of
cytokines into the circulation, and this response was augmented during
bacterial pneumonia. We speculate that the BAL procedure in subjects
with preexisting lung inflammation could augment the systemic
inflammatory response. This could be particularly injurious in subjects
with conditions such as septicemia, multiple trauma, shock complicated
by the SIRS, and multiple organ failure.
In summary, we have shown that the BAL procedure causes an increase in circulating cytokines, particularly IL-6 and G-CSF. The increase was associated with a systemic inflammatory response characterized by a neutrophilia. This is clearly an important variable for investigation using BAL when studying inflammatory lung conditions. We speculate that the alveolar macrophages make an important contribution to this release of cytokines. Although this inflammatory response induced by BAL was not injurious in the healthy volunteers, it could augment the systemic inflammatory response in subjects with underlying lung diseases.
| Footnotes |
|---|
= tumor necrosis factor-
Received for publication June 14, 2000. Accepted for publication October 27, 2000.
| References |
|---|
|
|
|---|
induced changes in circulating numbers of neutrophils and lymphocytes. J Immunol 139,3406-3415[Abstract]
This article has been cited by other articles:
![]() |
Y.-C. T. Huang, M. A. Bassett, D. Levin, T. Montilla, and A. J. Ghio Acute Phase Reaction in Healthy Volunteers After Bronchoscopy With Lavage Chest, June 1, 2006; 129(6): 1565 - 1569. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-W. Um, C.-M. Choi, C.-T. Lee, Y. W. Kim, S. K. Han, Y.-S. Shim, and C.-G. Yoo Prospective Analysis of Clinical Characteristics and Risk Factors of Postbronchoscopy Fever Chest, March 1, 2004; 125(3): 945 - 952. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |